Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
10.04
-0.19 (-1.86%)
At close: Aug 21, 2026, 4:00 PM EDT
10.20
+0.16 (1.59%)
After-hours: Aug 21, 2026, 7:37 PM EDT
Cartesian Therapeutics Employees
Cartesian Therapeutics had 75 employees as of December 31, 2025. The number of employees increased by 9 or 13.64% compared to the previous year.
Employees
75
Change (1Y)
9
Growth (1Y)
13.64%
Revenue / Employee
$19,693
Profits / Employee
-$2,025,213
Market Cap
303.76M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 75 | 9 | 13.64% | 75 | 0 |
| Dec 31, 2024 | 66 | 28 | 73.68% | 66 | 0 |
| Dec 31, 2023 | 38 | - | - | 37 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Bicycle Therapeutics | 288 |
| ProQR Therapeutics | 187 |
| Fate Therapeutics | 161 |
| Orchestra BioMed Holdings | 86 |
| SAB Biotherapeutics | 86 |
| InflaRx | 65 |
| Neumora Therapeutics | 63 |
RNAC News
- 15 days ago - Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewsWire
- 16 days ago - Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 16 days ago - Cartesian Therapeutics Quarterly report: Q2 2026 - Filings
- 16 days ago - Cartesian Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - Cartesian Therapeutics Announces New Employment Inducement Grant - GlobeNewsWire
- 2 months ago - Cartesian Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases - GlobeNewsWire
- 3 months ago - Cartesian Therapeutics secures up to $150M financing from K2 HealthVentures - TheFly